Mutual funds holding Dr Agarwal's Health Care shares
24 mutual fund schemes held Dr Agarwal's Health Care shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹1,654 cr in all. The largest holders by value are Invesco India Small Cap Fund (2.4% of the fund), Motilal Oswal Small Cap Fund (3.3% of the fund), Invesco India Large & Mid Cap Fund (1.3% of the fund).
Against the month before, 1 scheme added Dr Agarwal's Health Care as a new holding and 1 sold out of it completely.
New holders: PGIM India Flexi Cap Fund
Sold out: Motilal Oswal BSE 1000 Index Fund
By category: Sectoral/Thematic (6), Small Cap (5), ELSS (4), Multi Cap (3), Flexi Cap (3), Mid Cap (2).
8 actively managed schemes holding it are rated A+ or A on their track record, among them Invesco India Small Cap Fund, Invesco India Large & Mid Cap Fund, Invesco India Mid Cap Fund, Invesco India Flexi Cap Fund, PGIM India Small Cap Fund.
Every scheme holding Dr Agarwal's Health Care, by value
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Dr Agarwal's Health Care shares?
24 schemes held Dr Agarwal's Health Care in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹1,654 cr in all.
Which mutual fund holds the most Dr Agarwal's Health Care shares?
By value, Invesco India Small Cap Fund: about ₹388 cr, 2.38% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.